Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Excessive iron accumulation is one of the main pathogeneses of Parkinson's disease (PD). Ceruloplasmin plays an important role in keeping the iron homoeostasis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To explore the association between serum ceruloplasmin depletion and subcortical iron distribution in PD.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study type</h3><p>Prospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Population</h3><p>One hundred and twenty‐one normal controls, 34 PD patients with low serum ceruloplasmin (PD‐LC), and 28 patients with normal serum ceruloplasmin (PD‐NC).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Sequence</h3><p>Enhanced susceptibility‐weighted angiography (ESWAN) on a 3 T scanner.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Quantitative susceptibility mapping was employed to quantify the regional iron content by using a semi‐automatic method. Serum ceruloplasmin concentration was measured from peripheral blood sample. Clinical assessments were conducted by a neurologist.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>General linear model was used to compare the intergroup difference of region iron distribution among groups, and the statistics was adjusted by Bonferroni method (<i>P</i> < 0.01). Partial correlation analysis was used to detect the association between regional iron distribution and serum ceruloplasmin concentration (<i>P</i> < 0.05). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Compared with normal controls, significant iron accumulation in substantia nigra, putamen, and red nucleus was observed in PD‐LC, while the only region showing significant iron accumulation was SN in PD‐NC. Between PD‐NC and PD‐LC, the iron accumulation in putamen remained significantly different, which had a negative correlation with serum ceruloplasmin in whole PD patients (<i>r</i> = −0.338, <i>P</i> = 0.008). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>Nigral iron accumulation characterizes PD patients without significant association with serum ceruloplasmin. Differentially, when PD patients appear with reduced serum ceruloplasmin, more widespread iron accumulation would be expected with additionally involving putamen and red nucleus. All these findings provide insightful evidence for the abnormal iron metabolism behind the ceruloplasmin depletion in PD.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Evidence Level</h3><p>2</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy</h3><p>2</p></section>

Serum Uric Acid and Nigral Iron Deposition in Parkinson’s Disease: A Pilot Study

Genetic Impacts on Nigral Iron Deposition in Parkinson's Disease: A Preliminary Quantitative Susceptibility Mapping Study.

Region-Specific Iron Measured by MRI As a Biomarker for Parkinson’s Disease

Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.

Influence Of Regional Iron On The Motor Impairments Of Parkinson'S Disease: A Quantitative Susceptibility Mapping Study

Different Iron Deposition Patterns in Early- and Middle-Late-onset Parkinson's Disease.

Nigral Iron Deposition Influences Disease Severity by Modulating the Effect of Parkinson's Disease on Brain Networks

Decreased Serum Ceruloplasmin Levels Characteristically Aggravate Nigral Iron Deposition in Parkinson's Disease.

Iron deposition in substantia nigra: abnormal iron metabolism, neuroinflammatory mechanism and clinical relevance

Asymmetrical Nigral Iron Accumulation In Parkinson'S Disease With Motor Asymmetry: An Explorative, Longitudinal And Test-Retest Study

Iron-related Nigral Degeneration Influences Functional Topology Mediated by Striatal Dysfunction in Parkinson's Disease.

Nigral iron deposition occurs across motor phenotypes of Parkinson's disease.

Low plasma serotonin linked to higher nigral iron in Parkinson's disease

Serum Ceruloplasmin Depletion is Associated With Magnetic Resonance Evidence of Widespread Accumulation of Brain Iron in Parkinson's Disease

Correlation Between Substantia Nigra Hyperechogenicity and Iron Metabolism in the Postural Instability Gait Difficulty Subtype of Parkinson's Disease

Regional High Iron in the Substantia Nigra Differentiates Parkinson's Disease Patients from Healthy Controls.

Central Nervous System-Derived Exosomal Alpha-Synuclein in Serum May Be a Biomarker in Parkinson's Disease.

High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry

Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson’s Disease

Extra-basal ganglia iron content and non-motor symptoms in drug-naïve, early Parkinson’s disease

Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study.